Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback